Connect with us:   Email This Page  | Print
The information on this site is designed for patients. If you are a healthcare professional, click here.
Learn more about Neuronetics, developer of the NeuroStar TMS Therapy System.
NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. Click here for full prescribing and safety information
NeuroStar TMS Therapy is the first and only non-systemic and non-invasive TMS device cleared by the U.S. Food and Drug Administration (FDA) for the treatment of patients with major depression who have not benefited from prior antidepressant treatment.* NeuroStar TMS Therapy uses a highly focused, pulsed magnetic field to stimulate function in targeted brain regions.

NeuroStar TMS Therapy is:
  • Non-invasive, meaning that it does not involve surgery. It does not require any anesthesia or sedation, as the patient remains awake and alert during the treatment.
  • Non-systemic, meaning that it is not taken by mouth and does not circulate in the bloodstream throughout the body.
Download our Patient Education Brochure


Find a Doctor
Find a NeuroStar TMS Therapy provider in your area.
Learn more
Watch the Video
View our NeuroStar
TMS Therapy patient education video.
See the video
Read our
Patient Brochure
Click here to download our patient education brochure.
Download
Read Patient FAQs
Read answers to frequently asked questions about NeuroStar TMS
Therapy.
Learn more

Copyright © 2012 Neuronetics. All Rights Reserved Sitemap  | Privacy Policy  | Terms and Conditions  | Glossary

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.